Efficacy and safety of 28‐day treatment with oral insulin ( ORMD ‐0801) in patients with type 2 diabetes: A randomized, placebo‐controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of 28‐day treatment with oral insulin ( ORMD ‐0801) in patients with type 2 diabetes: A randomized, placebo‐controlled trial

Published:2021-08-18 Issue:11 Volume:23 Page:2529-2538
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Eldor Roy¹²^ORCID,Neutel Joel³,Homer Kenneth⁴^ORCID,Kidron Miriam⁵^ORCID

Affiliation:

1. Diabetes Unit, Institute for Endocrinology, Metabolism and Hypertension Tel Aviv Sourasky Medical Center Tel Aviv Israel

2. The Sackler Faculty of Medicine Tel‐Aviv University Tel‐Aviv Israel

3. Orange County Research Center Tustin California USA

4. Integrium, LLC Tustin California USA

5. Oramed Pharmaceuticals Jerusalem Israel

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14499

Reference27 articles.

1. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2. Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects

3. Oral Insulin: The Rationale for This Approach and Current Developments

4. Oral Insulin Delivery in a Physiologic Context: Review

5. Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02

2. Circumventing the Gastrointestinal Barrier for Oral Delivery of Therapeutic Proteins and Peptides (PPTS): Current Trends and Future Trajectories;Current Drug Delivery;2024-02

3. Electromechanical convective drug delivery devices for overcoming diffusion barriers;Journal of Controlled Release;2024-02

4. Evolution of insulin therapy: past, present, future;Problems of Endocrinology;2024-01-24

5. Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3